Leukemias are cancers of the blood or bone marrow. Lymphomas are cancers of the lymphocytes, a type of white blood cells that are part of the lymphatic system. Multiple myeloma is a blood cancer that affect plasma cells. Learn more about leukemias, lymphomas, and multiple myeloma.

The Duke Cancer Institute combines state-of-the-art, compassionate medical care with innovative science to improve outcomes for patients battling leukemias, lymphomas, myelomas, myelodysplasias, myeloproliferative disorders, aplasia, and other neoplastic diseases of the marrow or blood system.

Programs

The Duke Cancer Institute offers specialized programs to help our patients manage their treatments, access support services, and live a high quality of life:

• The Duke Hematologic Malignancies Program takes a holistic approach to address the medical, emotional, and practical needs of our patients.
• The Duke Center for Chronic Lymphocytic Leukemia (CLL) helps patients with CLL manage their disease.

Care Guides

News

Events

Clinical Trials

• Types of Leukemia
• Types of Lymphoma
• Types of Multiple Myeloma
• See all related care guides

• Experts Identify Critical Genes Mutated in Stomach Cancer
• Genetic Variation in East Asians Found to Explain Resistance to Cancer Drugs
• Discovery Could Reduce Chemotherapy's Side Effects
• See all related news

• May 23: Time with the Oncology Nutritionist: Berry Healthy
• May 24: Chemotherapy Orientation Class
• May 29: Chemotherapy Orientation Class
• See all related events

Learn about clinical trials offered by Duke Cancer Institute.